| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*
Laboratory of Immunology and
Laboratory of Retinal Cell and Molecular Biology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892
The Fas-Fas ligand (FasL) interaction is important for maintaining lymphocyte homeostasis by signaling for activation-induced cell death. Mice homozygous for the lpr or gld mutations do not express functional Fas or FasL, respectively, and spontaneously develop progressive autoimmune symptoms. Recent studies implicated expression of FasL on immunologically privileged tissues in protection from immune-mediated damage. Conversely, tissue expression of Fas may facilitate damage. We evaluated the susceptibility of lpr and gld mice to induction of experimental autoimmune uveitis (EAU), a T cell-mediated autoimmune disease induced with retinal Ags, which targets the neural retina. gld as well as lpr mice immunized with a retinal Ag developed disease of lower incidence and severity than wild-type controls. Delayed hypersensitivity responses were not significantly different among immunized gld, lpr, or wild-type mice, although in vitro Ag-specific lymphocyte responses of the mutant mice were lower. To evaluate whether the diminished ability of gld and lpr mice to develop EAU was due to a defect at the level of the tissue or the immune system, radiation bone marrow chimeras constructed between wild-type and mutant mice were immunized to induce EAU. Mutant recipients of wild-type bone marrow, but not wild-type recipients of mutant bone marrow, developed normal disease scores. These results indicate that normal expression of Fas and of FasL on cells of the immune system is important for EAU expression. Unexpectedly, neither lack of Fas nor lack of FasL on the ocular tissues affected expression of EAU.
This article has been cited by other articles:
|
|
 |
|
  S. J. Curnow, D. Scheel-Toellner, W. Jenkinson, K. Raza, O. M. Durrani, J. M. Faint, S. Rauz, K. Wloka, D. Pilling, S. Rose-John, et al. Inhibition of T Cell Apoptosis in the Aqueous Humor of Patients with Uveitis by IL-6/Soluble IL-6 Receptor trans-Signaling J. Immunol., October 15, 2004; 173(8): 5290 - 5297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Knox, A. E. Milner, N. K. Green, A. G. Eliopoulos, and L. S. Young Inhibition of Metalloproteinase Cleavage Enhances the Cytotoxicity of Fas Ligand J. Immunol., January 15, 2003; 170(2): 677 - 685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kim, K. A. Whartenby, R. W. Georgantas III, J. Wingard, and C. I. Civin Human CD34+ Hematopoietic Stem/Progenitor Cells Express High Levels of FLIP and Are Resistant to Fas-Mediated Apoptosis Stem Cells, March 1, 2002; 20(2): 174 - 182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wei, K. Chen, G. C. Sharp, H. Yagita, and H. Braley-Mullen Expression and Regulation of Fas and Fas Ligand on Thyrocytes and Infiltrating Cells During Induction and Resolution of Granulomatous Experimental Autoimmune Thyroiditis J. Immunol., December 1, 2001; 167(11): 6678 - 6686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. F. Shen, D. M. Matteson, N. Tuaillon, B. K. Suedekum, R. R. Buggage, and C.-C. Chan Involvement of Apoptosis and Interferon-{gamma} in Murine Toxoplasmosis Invest. Ophthalmol. Vis. Sci., August 1, 2001; 42(9): 2031 - 2036. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
